Fidelity Select Biotechnology Portfolio (FBIOX) est une société cotée en bourse dans le Santé secteur, opérant dans le Biotechnologie secteur d'activité.
FBIOX a date d'introduction en bourse 1985-12-16, cotée sur le NASDAQ, une capitalisation boursière de $5.27B.
Fidelity Select Biotechnology Portfolio is a non-diversified mutual fund that invests primarily in common stocks of biotechnology companies. The fund allocates at least 80% of its assets to companies engaged in the research, development, manufacture, and distribution of biotechnological products, services, and processes, as well as companies that benefit significantly from advances in biotechnology. The fund invests in both domestic and foreign issuers, utilizing fundamental analysis of financial condition, industry position, and market conditions to guide investment selection.
